6th Annual RNA Editing Summit | Boston, MA | July 29-31, 2025

Building Efficacious RNA Editors with Optimized Target Selection and Extra-Hepatic Delivery for Rare and Common Diseases

Speakers: Jacob Borrajo, Founder and Chief Executive Officer, Amber Bio, Steve Seedhouse, Managing Director, Biotech Equity Research, Cantor Fitzgerald, Keay Nakae, Director of Research, Chardan, Tehmina Masud, Vice President and Head of Systems and Target Biology, Deep Genomics, TJ Cradick, Chief Technology Officer, HuidaGene Therapeutics, Anna Dudkina, Independent RNA Editing Expert, Roger Song, Senior Equity Research Analyst, Jefferies, Vincent DiGiacomo, Director, Therapeutic Innovation, Jorna Therapeutics, Venkat Krishnamurthy, Senior Vice President and Head of Platform, Korro Bio, Ram Aiyar, Chief Executive Officer, Korro Bio, Gerard Platenburg, Chief Scientific Officer, ProQR Therapeutics, Andrew Fraley, Chief Innovation Officer, Radar Therapeutics, Robert Deans, Chief Technology Officer, Rett Syndrome Research Trust, Yang Gao, Assistant Professor, Rice University, Brian Booth, Director Computational Biology RNAfix, Shape Therapeutics, Chad Weldy, Instructor, Cardiovascular Medicine, Stanford University, Peter Nell, Chief Execuitve Officer, Stealth Biotech, Peter Beal, Professor, University of Calfornia Davis, Artem Nemudryi, Assistant Professor, University of Florida, Paul Bolno, Chief Executive Officer, Wave Life Sciences